| Next 10 |
Ad
VNDA Articles Vanda Pharmaceuticals Inc.
home / stock / vnda / vnda articles
Articles | Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)
-
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading lower after Future Pak withdrew its proposal to purchase the company. “Consistent...
-
Shares of Jabil Inc. (NYSE:JBL) fell sharply during Thursday's session following third-quarter results. Jabil reported third-quarter fiscal 20...
-
Shares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with ...
-
U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Tesla Inc (NASDAQ:TSLA) rose sharply during Thurs...
-
Shares of G-III Apparel Group, Ltd. (NASDAQ:GIII) fell sharply during Thursday's session after the company reported worse-than-expected quarte...
-
U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 50 points on Thursday. The Dow traded up 0.14% to 38,860.4...
-
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) received an acquisition offer from Cycle Pharmaceuticals Ltd worth $8 per share, representing a total cash...
-
U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Thursday. Shares of Exact Sciences Corporation (NASDA...
-
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) attempt to revive patents...
Stock Information
Get VNDA Alerts
News, Short Squeeze, Breakout and More Instantly...
Vanda Pharmaceuticals Inc. Company Name:
VNDA Stock Symbol:
NASDAQ Market:
Vanda Pharmaceuticals Inc. Website:
Ad
-
Vanda Pharmaceuticals Announces Participation at November 2024 Investor Conferences PR Newswire WASHINGTON , Nov. 12, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ) today announced that the company will participate in the following up...
-
Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire Revenues for Q3 2024 were $47.7 million , an increase of 23% compared to Q3 2023 Financial Guidance revised for Full Year 2024, raising the midpoint of revenue and cash ranges ...
-
Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024 PR Newswire Conference Call and Webcast to Follow WASHINGTON , Oct. 30, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced ...